Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans.

Islets

Volumn 1, Issue 1, 2009, Pages 42-49

  Melzi, Raffaella ^a   Maffi, Paola ^b   Nano, Rita ^b   Sordi, Valeria ^b   Mercalli, Alessia ^b   Scavini, Marina ^b   Secchi, Antonio ^b   Bonifacio, Ezio ^b   Piemonti, Lorenzo ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CLINICAL TRIAL; DRUG EFFECT; DRUG SCREENING; FEMALE; GRAFT SURVIVAL; HETEROTOPIC TRANSPLANTATION; HUMAN; LIVER; MALE; METHODOLOGY; MOUSE; PANCREAS ISLET TRANSPLANTATION; SPECIES DIFFERENCE; TIME;

ADULT; ANIMALS; DRUG EVALUATION, PRECLINICAL; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SIROLIMUS; SPECIES SPECIFICITY; TIME FACTORS; TRANSPLANTATION, HETEROTOPIC;

EID: 79953251890     PISSN: None     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.1.1.8881     Document Type: Article

References (0)